Title

Director, Tulane Cancer Center

Specialty/Subspecialty

Clinical Interest(s)

Research Interest(s)

Current / Former SSCI Roles

About Stefan C. Grant, MD, JD, MBA

Stefan C. Grant, MD, JD, MBA, is the Director of the Tulane Cancer Center, Chief of the Section of Hematology and Medical Oncology in the John W. Deming Department of Medicine at Tulane University School of Medicine and Deputy Director of the Louisiana Cancer Research Center. Dr. Grant is a thoracic medical oncologist who comes to Tulane from Wake Forest University School of Medicine, where he was Professor of Medicine in the Section of Hematology and Oncology and served as Associate Director for Clinical Trial Operations within the National Cancer Institute (NCI) designated Wake Forest Baptist Comprehensive Cancer Center. Additionally, he was Director for Intellectual Property Strategy and Maintenance at Wake Forest’s Center for Technology Innovation and Commercialization. Previously, Dr. Grant served as Medical Director of the Hematology Oncology Clinic at Acton Road at the University of Alabama at Birmingham (UAB) and within its NCI-designated Comprehensive Cancer Center. Dr. Grant is board certified in internal medicine and medical oncology. He obtained his medical degree from the University of the Witwatersrand in Johannesburg, South Africa, and underwent postgraduate training in South Africa and the United Kingdom. He completed his residency in Internal Medicine at the Albert Einstein Medical Center in Philadelphia and his fellowship in Hematology and Oncology at Memorial Sloan-Kettering Cancer Center in New York. After completing his fellowship, he joined the faculty of Memorial Sloan-Kettering within the Thoracic Oncology Service of the Division of Solid Tumor Oncology at Weill Cornell Medical College. While in New York, he obtained his J.D. from Fordham University School of Law. He is a member of the New York state bar and is a registered patent attorney. In addition, Dr. Grant holds an MBA from UAB’s Collat School of Business. Dr. Grant’s research has been focused on immunologic approaches to the treatment of lung cancer, the use of targeted therapies, and pragmatic clinical trials. Dr. Grant served a three-year term as a member of the steering committee of the Association of American Cancer Institute Clinical Research Innovation and is a fellow of the American College of Physicians.